Amphenol's Brazilian BDR Holders Face a Double Calendar Squeeze as Record Orders Tell the Real Story

Amphenol's BDR holders face a tight September-October calendar: 2-for-1 split and Q3 dividend. Q2 results beat, with record orders and margin expansion.

The connector maker's Brazilian investors are staring down a tightly packed stretch of corporate actions that demands careful attention to the calendar. Amphenol has confirmed a distribution of 0.04 real per Brazilian depositary receipt for the third quarter of 2026, with the securities trading ex-rights from September 18 and payment scheduled for October 20. That dividend event lands barely two weeks after the mechanics of the previously announced 2-for-1 split play out for BDR holders — shares go ex-split on September 2, with new units credited on September 4, while those holding BDRs on September 1 receive their additional entitlement. The US listing follows its own timeline, with the split taking effect on September 3.

The Numbers That Matter More Than the Mechanics

Strip away the corporate action logistics, though, and the underlying business tells a far more compelling story. Amphenol's second-quarter results, released in late July, showed adjusted earnings per share of $1.35 against revenue of $8.76 billion — a 55 percent year-on-year jump that landed 7.5 percent above analyst forecasts. The earnings beat was even more pronounced, coming in 16.4 percent ahead of expectations. Perhaps the most striking figure: order intake hit a record $10.7 billion, pushing the book-to-bill ratio to 1.23, while adjusted operating margin expanded by 420 basis points to an all-time high of 29.8 percent.

Management has already laid out an ambitious third-quarter roadmap, calling for revenue between $9.3 billion and $9.4 billion and adjusted EPS of $1.40 to $1.42 pre-split — or $0.70 to $0.71 on the adjusted basis. The full-year contribution from the acquired CommScope CCS business has been revised upward to $4.6 billion from a prior $4.1 billion, with the expected earnings dilution flipping to a positive $0.30 per share.

Insider Sales: A Familiar Pattern, Not a Red Flag

The recent insider activity at the highest levels of the company might raise eyebrows at first glance. CFO Craig A. Lampo exercised 193,200 options at $22.3725 on August 4 and sold the shares at a weighted average of $167.31, while HR chief David M. Silverman did the same with 120,000 options at $21.995 on August 5, selling at an average of $174.24. Lampo subsequently transferred 54,547 shares indirectly into a trust. Combined, the insider sales total roughly $20.9 million.

But context matters. These options carried strike prices set decades ago — exercising and taking profits at current levels is standard practice, not a signal of waning confidence. The record order book and expanding margins offer far more insight into the company's trajectory than these routine transactions.

A Stock in Consolidation, Not Crisis

The shares have been in a cooling-off phase since the split took effect in September, trading roughly 9 percent below their immediate post-split level. Friday's close of €136.74 represented a 1.3 percent decline, though the stock had gained 2.5 percent over the prior week. Monday's session saw the shares ease another 0.5 percent to €136.02.

The current price sits about 13 percent below the 52-week high of €156.26 reached in late June, yet the longer-term picture remains firmly constructive. The stock has climbed 45 percent over the past twelve months and is up 17 percent year-to-date. For those measuring from the September 2 annual low, the recovery amounts to a remarkable 50 percent gain.

What to Watch in the Weeks Ahead

The near-term narrative for Amphenol will hinge on whether the operational momentum from AI-driven data center demand can reclaim the spotlight from the technical calendar events. The September and October dates now provide a clear roadmap for both US and Brazilian shareholders, but the fundamental drivers — record orders, surging margins, and a strategically upgraded acquisition — suggest the company's growth story extends well beyond any single quarter's corporate actions. The recent share price weakness looks more like a pause than a reversal, though the coming weeks will test whether the market agrees.